The Real Question Behind CrowdStrike Stock’s Premium Price

CRWD: CrowdStrike logo
CRWD
CrowdStrike

The cybersecurity leader looks expensive on paper, but the price you pay falls sharply on future earnings, if you believe the growth story.

If you’ve glanced at CrowdStrike (CRWD) stock, you’ve likely seen the price tag and moved on. Trading at about 234.6 times its last twelve months of adjusted earnings, the stock screens as prohibitively expensive. But that headline number doesn’t tell the whole story. For a patient holder, the price you’re really paying is quite a bit lower.

Image by Gerd Altmann from Pixabay

What Patience Buys You

Look two years out, and the picture changes. Based on what analysts expect the company to earn by fiscal 2028, today’s price of about $231 a share is only about 140 times those future earnings. That’s a 40% lower multiple, a discount that materializes as earnings grow into the current stock price. It’s worth noting that while both the trailing and forward multiples are on an adjusted, non-GAAP basis, the definitions are not identical, so a small part of this shift comes from the earnings basis itself. Still, the core driver is a powerful assumption about growth.

Relevant Articles
  1. The Real Risk Inside Cisco Stock
  2. ANET Has Left Its Peers Behind. Or Has It?
  3. The Real Price of Marvell Stock’s Growth
  4. Amgen Stock Signals Its Confidence. The Market Agrees.
  5. Get Paid 12% A Year To Wait For INTU Stock To Go On Sale
  6. How To Bank 8.8% A Year On IBM Stock Before Buying A Single Share

And CrowdStrike is far from alone: which 10 S&P 500 stocks carry the biggest hidden forward discount? Our rankings sort the entire index by how little you are really paying for each name’s growth once the out-year earnings land.

Testing the Growth Engine

The honest question is not the price tag, but whether the growth that produces this discount is believable. Wall Street consensus sees revenue growing about 23% a year through 2028. That’s roughly in line with the 24% the company delivered over the last twelve months and the 26% it posted in its most recent quarter. On the top line, analysts are not forecasting a heroic leap.

The valuation discount, however, comes from earnings growing even faster than revenue. This implies expanding profit margins, a story management is actively telling. On its latest earnings call, the company reported “all-time record operating income” and pointed to “increased operating efficiency” as a key driver. Critically, the analyst consensus for this year’s earnings of about $1.25 per share lands squarely within management’s own guidance of $1.25 to $1.26. When analysts and management are aligned, the forecast carries more weight.

Management credits this acceleration to what it calls the “Mythos moment,” an inflection point where securing new AI models has become a top priority for customers. This is driving demand for new products like AIDR and fueling platform adoption through its FalconFlex subscription model, which saw its associated annual recurring revenue grow 101% year over year.

The Price of High Expectations

A stock priced for this kind of growth is sensitive to shifts in sentiment. In past market shocks, CRWD has fallen as much as 50% from its peak. The market’s occasional impatience with high-growth names is a real risk, as a recent five-day slide in the stock demonstrates. The forward discount rewards patience, but it doesn’t eliminate volatility.

It’s crucial to understand how the payoff works. If the stock price never moves, by 2028 you’d simply own a company trading at 140.0 times earnings. This proves you didn’t overpay, but it’s not a gain. That’s your margin of safety. The actual reward only comes if the market continues to value the company at a richer multiple as those earnings arrive. For instance, if the multiple settles at about 187.3 times, midway between today’s level and that 2028 floor, the stock would be about 34% higher.

The Real Price of Admission

The premium you see today is not necessarily the price you are paying for the long term. On the earnings expected just two years from now, the valuation becomes more grounded. If that growth arrives, you haven’t overpaid, even if the stock stands still. And if the market keeps its enthusiasm for CrowdStrike’s role in securing the AI revolution, the stock price should compound along with those earnings. The key metric to watch is net new annual recurring revenue. Management just raised its full-year growth outlook for that figure to 34%, a significant jump. Whether the company can deliver on that new, higher bar will tell you if the growth story is on track.

Own The Growth Without Overpaying

Whether you already hold CrowdStrike or you are weighing it now, the appeal is not that the stock is secretly cheap today. It is that you are not overpaying for the growth: on the earnings analysts expect two years out, you are paying an ordinary multiple, even if the price never moves.

The upside sits on top of that. If the market keeps paying anything close to today’s multiple as those earnings actually arrive, the price compounds with them. The one catch is that it all rides on a single company’s numbers coming through. And if it is exposure to software as a whole you want rather than this one name, a software ETF like IGV covers that theme, though that still leaves you riding a single slice of the market. That is why the Trefis High Quality (HQ) Portfolio does not lean on any single name: it uses this same valuation-discount discipline to size a measured allocation to strong growth like this, inside a diversified set of 30 high-conviction stocks, re-balanced as the estimates change and with a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.